Literature DB >> 18443923

Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.

Vincenzo Savini1, Chiara Catavitello, Assunta Manna, Marzia Talia, Fabio Febbo, Andrea Balbinot, Francesco D'Antonio, Giovanni Di Bonaventura, Claudio Celentano, Marco Liberati, Raffaele Piccolomini, Domenico D'Antonio.   

Abstract

Genitourinary infections caused by non-Candida yeasts are uncommon, and especially due to Saccharomyces cerevisiae. We describe the cases of two adult females with vulvovaginal infections caused by itraconazole-resistant S. cerevisiae who made a full recovery after oral fluconazole therapy. We also provide a concise review of recently published studies on this topic.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18443923     DOI： 10.1007/s11046-008-9119-y

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  36 in total

1.  Yeasts and fluconazole susceptibility in the Philippines.

Authors:  G S Bulmer; M L Marquez; L Co-Barcelona; R A Fromtling
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method.

Authors:  M J McCullough; K V Clemons; C Farina; J H McCusker; D A Stevens
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa.

Authors:  N Lehrer; E Segal; H Lis; Y Gov
Journal:  Mycopathologia       Date:  1988-05       Impact factor: 2.574

4.  Susceptibility profile of vaginal yeast isolates from Brazil.

Authors:  M A Ribeiro; R Dietze; C R Paula; D A Da Matta; A L Colombo
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

5.  Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.

Authors:  Xisto Sena Passos; Carolina Rodrigues Costa; Crystiane Rodrigues Araújo; Elisa Sales Nascimento; Lúcia Kioko Hasimoto e Souza; Orionalda de Fátima Lisboa Fernandes; Werther Souza Sales; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2007-03-01       Impact factor: 2.574

6.  Immunoglobulin classes of human serum antibodies in vaginal candidiasis.

Authors:  D W Warnock; J D Milne; A M Fielding
Journal:  Mycopathologia       Date:  1978-08-10       Impact factor: 2.574

7.  Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

Authors:  Monika Sojakova; Denisa Liptajova; Miroslav Borovsky; Julius Subik
Journal:  Mycopathologia       Date:  2004-02       Impact factor: 2.574

8.  Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.

Authors:  Valda Teixeira Figueiredo; Daniel de Assis Santos; Maria Aparecida Resende; Júnia Soares Hamdan
Journal:  Mycopathologia       Date:  2007-06-06       Impact factor: 2.574

9.  Susceptibility of clinical isolates of yeasts to anti-fungal agents.

Authors:  S M Hussain Qadri; D J Flournoy; S G Qadri; E G Ramirez
Journal:  Mycopathologia       Date:  1986-09       Impact factor: 2.574

10.  [Effectiveness of econazole on pregnant women with vulvo-vaginal candidiasis].

Authors:  C Marcano; M Feo
Journal:  Mycopathologia       Date:  1983-02-17       Impact factor: 2.574
View more
  6 in total

1.  Saccharomyces cerevisiae vaginitis: microbiology and in vitro antifungal susceptibility.

Authors:  María Julia Echeverría-Irigoyen; Elena Eraso; Josep Cano; María Gomáriz; Josep Guarro; Guillermo Quindós
Journal:  Mycopathologia       Date:  2011-03-22       Impact factor: 2.574

2.  Saccharomyces cerevisiae versus Candida in the Liofilchem(®) A.F. Genital System.

Authors:  Vincenzo Savini; Roberta Marrollo; Claudio Farina; Paolo Fazii; Domenico D'Antonio
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

3.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

4.  Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth.

Authors:  J Zupan; Z Tomičić; P Raspor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-27       Impact factor: 3.267

5.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

6.  [Candida glabrata : pathogenicity and therapy update].

Authors:  H-J Tietz
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.